Divining without seeds: The case for strengthening laboratory medicine in Africa

Divining without Seeds: The Case for Strengthening Laboratory Medicine in Africa

Volumn , Issue , 2011, Pages 1-222

  Okeke, Iruka N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955752422     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (517)

1. Abalaka, J. O. 2004. Attempts to cure and prevent HIV/AIDS in central Nigeria between 1997 and 2002: Opening a way to a vaccine-based solution to the problem? Vaccine 22 (29-30):3819-28.
2. Abalaka, J. O. 2005. [Design, development, and successful application of safe and effective HIV therapeutic and prophylactic vaccines]. Zhonghua Nan Ke Xue 11 (1):8-16. Abstracted by Medline.
3. Abrams, M. E. 1979. Costs of tests. J R Coll Physicians Lond 13 (4):217-18.
4. The Abuja Declaration and the Plan of Action. 2000.
5. Acholonu, Catherine Obianuju. 1999. The Igbo roots of Olaudah Equiano: An anthropological research. Owerri, Nigeria: Afa Publications.
6. Addae, Stephen. 1997. The evolution of modern medicine in a developing country: Ghana 1880-1960. Edinburgh: Durham Academic Press.
7. Adegbola, R. A., P. C. Hill, O. Secka, et al. 2006. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health 11 (7):1128-35.
8. Adegbola, R. A., O. Secka, G. Lahai, et al. 2005. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: A prospective study. Lancet 366 (9480):144-50.
9. Adio, Waziri. 2004. Between AIDS and development. ThisDay, 9 December.
10. Agadzi, V. K., Y. Aboagye-Atta, J. W. Nelson, D. R. Hopkins, and P. L. Perine. 1985. Yaws in Ghana. Rev Infect Dis 7 Suppl 2:S233-36.
11. Agadzi, V. K., Y. Aboagye-Atta, J. W. Nelson, P. L. Perine, and D. R. Hopkins. 1983. Resurgence of yaws in Ghana. Lancet 2 (8346):389-90.
12. Aledort, J. E., A. Ronald, M. E. Rafael, et al. 2006. Reducing the burden of sexually transmitted infections in resource-limited settings: The role of improved diagnostics. Nature 444 Suppl 1:59-72.
13. Alibek, Ken, and Stephen Handelman. 1999. Biohazard: The chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. New York: Random House.
14. Alikor, D. E., and N. O. Erhabor. 2006. Trend of HIV-seropositivity among children in a tertiary health institution in the Niger Delta Region of Nigeria. Afr J Health Sci 13 (1-2):80-85.
15. Alsop Z. 2007. Ebola outbreak in Uganda "atypical," say experts. Lancet 370 (9605):2085.
16. Alubo, O. 2001. The promise and limits of private medicine: Health policy dilemmas in Nigeria. Health Policy Plan 16 (3):313-21.
17. AMFm, Task Force. 2007. Affordable Medicines Facility-Malaria: Technical design. Roll Back Malaria partnership.
18. Amin, A. A., D. Zurovac, B. B. Kangwana, et al. 2007. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J 6:72.
19. Amirali, W., C. Moshiro, and K. Ramaiya. 2004. Assessment of clinical case-definition for HIV/AIDS in Tanzania. East Afr Med J 81 (1):226-29.
20. Andre, M., M. Eriksson, S. Molstad, C. Stalsbylundborg, A. Jacobsson, and I. Odenholt. 2005. The management of infections in children in general practice in Sweden: A repeated 1-week diagnosis-prescribing study in 5 counties in 2000 and 2002. Scand J Infect Dis 37 (11-12):863-69.
21. Antonio, M., H. Dada-Adegbola, E. Biney, et al. 2008. Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis 8:81.
22. APUA, Alliance for the Prudent Use of Antibiotics. 2001. Antibiotic resistance: Synthesis of recommendations by expert policy groups. Geneva: Alliance for the Prudent Use of Antibiotics, World Health Organization.
23. Araya, T., G. Reniers, A. Schaap, et al. 2004. Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, Ethiopia. Trop Med Int Health 9 (1):178-86.
24. Arrow, K. J., C. B. Panosian, and H. Gelband, eds. 2004. Saving lives, buying time: Economics of malaria drugs in an age of resistance. Washington, D.C.: National Academies Press.
25. Arthur, R. R. 2002. Ebola in Africa-discoveries in the past decade. Euro Surveill 7 (3):33-6.
26. Atta, Sefi. 2005. Everything good will come: A novel. Northampton, Mass.: Interlink Books.
27. Attaran, A. 2005. An immeasurable crisis? A criticism of the Millennium Development Goals and why they cannot be measured. PLoS Med 2 (10):318.
28. Attaran, A., K. I. Barnes, C. Curtis, et al. 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363 (9404):237-40.
29. Aylward, B., K. A. Hennessey, N. Zagaria, J. M. Olive, and S. Cochi. 2000. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 90 (10):1515-20.
30. Aylward, R. B. 2006. Eradicating polio: Today's challenges and tomorrow's legacy. Ann Trop Med Parasitol 100 (5-6):401-13.
31. Aylward, R. B., and M. Birmingham. 2005. The human story. Br Med J 331 (7527):1261-62.
32. Baker, S., M. Favorov, and G. Dougan. 2010. Searching for the elusive typhoid diagnostic. BMC Infect Dis 10 (1):45.
33. Balter, M. 2000. Malaria: Can WHO roll back malaria? Science 290 (5491):430.
34. Baquero, F., and J. Campos. 2003. The tragedy of the commons in antimicrobial chemotherapy. Rev Esp Quimioter 16 (1):11-13.
35. Barker, R. H., Jr., L. Suebsaeng, W. Rooney, G. C. Alecrim, H. V. Dourado, and D. F. Wirth. 1986. Specific DNA probe for the diagnosis of Plasmodium falciparum malaria. Science 231 (4744):1434-46.
36. Barrett, S. 2004. Eradication versus control: The economics of global infectious disease policies. Bull World Health Organ 82 (9):683-88.
37. Barrett, S. 2006. The smallpox eradication game. Public Choice 130:179-207.
38. Basnyat, B. 2005. Typhoid and paratyphoid fever. Lancet 366 (9497):1603.
39. Basnyat, B., A. P. Maskey, M. D. Zimmerman, and D. R. Murdoch. 2005. Enteric (typhoid) fever in travelers. Clin Infect Dis 41 (10):1467-72.
40. Basu, S., J. R. Andrews, E. M. Poolman, et al. 2007. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: An epidemiological modelling study. Lancet 370 (9597):1500.
41. Basu, S., G. H. Friedland, J. Medlock, et al. 2009. Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci 106 (18):7672-77.
42. Bateman, C. 2006. Taking uBhejane by the horn(s). S Afr Med J 96 (5):382-86.
43. Bausch, D. G., M. Borchert, T. Grein, et al. 2003. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis 9 (12):1531-37.
44. Bausch, D. G., A. H. Demby, M. Coulibaly, et al. 2001. Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis 1 (4):269-81.
45. Bausch, D. G., S. T. Nichol, J. J. Muyembe-Tamfum, et al. 2006. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med 355 (9):909-19.
46. Bausch, D. G., P. E. Rollin, A. H. Demby, et al. 2000. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38 (7):2670-77.
47. Bausch, D. G., S. S. Sesay, and B. Oshin. 2004. On the front lines of Lassa fever. Emerg Infect Dis 10 (10):1889-90.
48. Beatty, Alexandra S., Kimberly A. Scott, Peggy Tsai, Institute of Medicine (U.S.). Committee on Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin, Institute of Medicine (U.S.). Board on Global Health, and National Research Council (U.S.). Board on Agriculture and Natural Resources. 2008. Achieving sustainable global capacity for surveillance and response to emerging diseases of zoonotic origin: Workshop report. Washington, D.C.: National Academies Press.
49. Behets, F., A. Disasi, R. W. Ryder, et al. 1991. Comparison of five commercial enzymelinked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa. J. Clin. Microbiol. 29 (10):2280-84.
50. Bell, D. R., P. Jorgensen, E. M. Christophel, and K. L. Palmer. 2005. Malaria risk: Estimation of the malaria burden. Nature 437 (7056):E3-4; discussion, E4-5.
51. Bell, D., and M. D. Perkins. 2008. Making malaria testing relevant: Beyond test purchase. Trans R Soc Trop Med Hyg 102 (11):1064-66.
52. Bell, D., C. Wongsrichanalai, and J. W. Barnwell. 2006. Ensuring quality and access for malaria diagnosis: How can it be achieved? Nat Rev Microbiol 4 (9):682-95.
53. Bellina, L., and E. Missoni. 2009. Mobile cell-phones (M-phones) in telemicroscopy: Increasing connectivity of isolated laboratories. Diagn Pathol 4:19.
54. Bello, I. S., F. A. Arogundade, A. A. Sanusi, I. T. Ezeoma, E. A. Abioye-Kuteyi, and A. Akinsola. 2004. Knowledge and utilization of Information Technology among health care professionals and students in Ile-Ife, Nigeria: A case study of a university teaching hospital. J Med Internet Res 6 (4):e45.
55. Berhan, Y. 2008. Medical doctors profile in Ethiopia: Production, attrition and retention. In memory of 100-years Ethiopian modern medicine & the new Ethiopian millennium. Ethiop Med J 46 Suppl 1:1-77.
56. Berhane, Y. 2004. Challenges in advancing public health. Ethiop J Health Dev 18 (1):1.
57. Berkelman, R., G. Cassell, S. Specter, M. Hamburg, and K. Klugman. 2006. The "Achilles Heel" of global efforts to combat infectious diseases. Clin Infect Dis 42 (10):1503-4.
58. Berkley, J. A., B. S. Lowe, I. Mwangi, et al. 2005. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 352 (1):39-47.
59. Bertherat, E., S. Bekhoucha, S. Chougrani, et al. 2007. Plague reappearance in Algeria after 50 years, 2003. Emerg Infect Dis 13 (10):1459-62.
60. Biggar, R. J., P. L. Gigase, M. Melbye, et al. 1985. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 2 (8454):520-53.
61. Bill and Melinda Gates Foundation. 2007. Bill and Melinda Gates call for new global commitment to chart a course for malaria eradication. http://www.gatesfoundation.org/press-releases/Pages/course-for-malaria-eradication- 071017-2.aspx.
62. Bizuwork, T., S. D. Makombe, K. Kamoto, and A. D. Harries. 2007. WHO stage 3 disease conditions and outcomes in patients started on antiretroviral therapy in Malawi. J Infect Devel Ctries 1 (2):118-22.
63. Blair, D. M. 1956. Bilharziasis survey in British West and East Africa, Nyasaland and the Rhodesias. Bull World Health Organ 15:203-73.
64. Blomberg, B., K. P. Manji, W. K. Urassa, et al. 2007. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: A prospective cohort study. BMC Infect Dis 7:43.
65. Boehme, C. C., P. Nabeta, G. Henostroza, et al. 2007. Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol 45 (6):1936-40.
66. Bohannon, J. 2006. Arata Kochi profile: Fighting words from WHO's new malaria chief. Science 311 (5761):599.
67. Bonnet, M. J., P. Akamituna, and A. Mazaya. 1998. Unrecognized Ebola hemorrhagic fever at Mosango Hospital during the 1995 epidemic in Kikwit, Democratic Republic of the Congo. Emerg Infect Dis 4 (3):508-10.
68. Bosompem, K. M., I. Ayi, W. K. Anyan, T. Arishima, F. K. Nkrumah, and S. Kojima. 1997. A monoclonal antibody-based dipstick assay for diagnosis of urinary schistosomiasis. Trans R Soc Trop Med Hyg 91 (5):554-56.
69. Breman, J. G., and C. N. Holloway. 2007. Malaria surveillance counts. Am J Trop Med Hyg 77 (6 Suppl):36-47.
70. Breman, J. G., P. Piot, K. M. Johnson, et al. 1977. The epidemiology of Ebola haemorrhagic fever in Zaire, 1976. Paper read at Ebola Virus Haemorrhagic Fever conference, Antwerp, Belgium.
71. Breslauer, D. N., R. N. Maamari, N. A. Switz, W. A. Lam, and D. A. Fletcher. 2009. Mobile phone based clinical microscopy for global health applications. PLoS One 4 (7):e6320.
72. Brieger, W. R., P. E. Osamor, K. K. Salami, O. Oladepo, and S. A. Otusanya. 2004. Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan 19 (3):177-82.
73. Briese, Thomas, Janusz T. Paweska, Laura K. McMullan, et al. 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa. PLoS Pathog 4 (5):e1000455.
74. British contributions to medical research and education in Africa after the Second World War. 2001. Wellcome Witness Seminar 10: British contributions to medical research and education in Africa after the Second World War, Wellcome Trust, London.
75. Brock, Thomas D. 1999. Milestones in microbiology 1546 to 1940. Washington, D.C.: ASM Press.
76. Brown, R. C. 1996. Antibiotic sensitivity testing for infections in developing countries: Lacking the basics. JAMA 276 (12):952-53.
77. Bryce, J., C. Boschi-Pinto, K. Shibuya, and R. E. Black. 2005. WHO estimates of the causes of death in children. Lancet 365 (9465):1147-52.
78. Burnum, J. F. 1986. Medical vampires. N Engl J Med 314 (19):1250-51.
79. Campbell, C. C. 2008. Halting the toll of malaria in Africa. Am J Trop Med Hyg 78 (6):851-53.
80. Carson, Rachel. 2002. Silent spring. 40th anniversary ed. Boston: Houghton Mifflin.
81. Carter, K. Codell. 2003. The rise of causal concepts of disease: Case histories, the history of medicine in context. Burlington, Vt.: Ashgate.
82. CBoH, Central Board of Health 2003. Guidelines for the diagnosis and treatment of malaria in Zambia. Lusaka, Zambia: Central Board of Health.
83. CBoH, Central Board of Health 2006. A roadmap for impact on malaria in Zambia. Lusaka, Zambia: Ministry of Health.
84. CDC, Centers for Disease Control and Prevention. 2010. Nigeria won: Guinea worms zero. In Guinea worm wrap-up #194. WHO Collaborating Center for Research, Training and Eradication of Dracunculiasis.
85. Chain, E., H. W. Florey, A. D. Gardner, et al. 1940. Penicillin as a chemotherapeutic agent. Lancet ii, 226-28.
86. Chambers, R. 1989. Vulnerability: How the poor cope. Institute of Development Studies Bulletin, April 2.
87. Chandler, C. I., R. Mwangi, H. Mbakilwa, R. Olomi, C. J. Whitty, and H. Reyburn. 2008. Malaria overdiagnosis: Is patient pressure the problem? Health Policy Plan 23 (3):170-78.
88. Chanteau, S., S. Dartevelle, A. E. Mahamane, S. Djibo, P. Boisier, and F. Nato. 2006. New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Med 3 (9):e337.
89. Chanteau, S., L. Rahalison, L. Ralafiarisoa, et al. 2003. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 361 (9353):211-16.
90. Chappuis, F., S. Sundar, A. Hailu, et al. 2007. Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5 (11):873-82.
91. Cheesebrough, M. 1984. Medical laboratory manual for tropical countries. Vol. 2 of 2 vols. Oxford: Butterworth-Heinemann.
92. Chigwedere, P., and M. Essex. 2010. AIDS denialism and public health practice. AIDS Behav. 14(2):237-47.
93. Chigwedere, P., G. R. Seage, S. Gruskin, T. H. Lee, and M. Essex. 2008. Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr. 49(4):410-15.
94. Close, William T. 1995. Ebola: A documentary novel of its first explosion. New York: Ivy Books.
95. Cohen, G. M. 2007. Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries. AIDS 21 Suppl 4:S81-87.
96. Cohen, J. 2004. Containing the threat-don't forget Ebola. PLoS Med 1 (3):e59.
97. Colonial Office, U.K. 1948. A doctor in Nigeria. Wellcome Film.
98. Commission for Africa. 2005. Our common interest. London: Penguin Books.
99. Cooper, C. B., W. R. Gransden, M. Webster, et al. 1982. A case of Lassa fever: Experience at St Thomas's Hospital. Br Med J (Clin Res Ed) 285 (6347):1003-5.
100. Cox, F. E. G., ed. 1996. Illustrated history of tropical diseases. Wellcome Trust.
101. Cox, H., Y. Kebede, S. Allamuratova, et al. 2006. Tuberculosis recurrence and mortality after successful treatment: Impact of drug resistance. PLoS Med 3 (10):e384.
102. Craft, D. W., and S. W. Riddell. 2005. Deployed clinical microbiology support to a developing country. Sunrise symposium at the American Society for Microbiology 105th general meeting, Atlanta, Georgia.
103. Creager, Angela N. H., and Hannah Landecker. 2009. Technical matters: Method, knowledge and infrastructure in twentieth-century life science. Nat Methods 6 (10):701.
104. Cunningham, Andrew. 1992. Transforming plague: The laboratory and the identity of infectious disease. In The laboratory revolution in medicine, edited by A. Cunningham and P. Williams. Cambridge: Cambridge University Press.
105. Curtin, Philip, D. 1990. The end of the "white man's grave"? Nineteenth-century mortality in West Africa. Journal of Interdisciplinary History 21 (1):63-88.
106. D'Acremont, V., C. Lengeler, H. Mshinda, D. Mtasiwa, M. Tanner, and B. Genton. 2009. Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med 6 (1):e252.
107. D'Alessandro, U., A. Talisuna, and M. Boelaert. 2005. Editorial: Should artemisininbased combination treatment be used in the home-based management of malaria? Trop Med Int Health 10 (1):1-2.
108. Daly, C. C., I. Hoffman, M. Hobbs, et al. 1997. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: Comparison of methods. J Clin Microbiol 35 (11):2985-88.
109. Davies, J. N. 1956. The history of syphilis in Uganda. Bull World Health Organ 15 (6):1041-55.
110. Declaration of Alma-Ata. 1978. International Conference on Primary Health Care, 6-12 September, Alma-Ata, USSR.
111. de Oliveira, A. M., J. Skarbinski, P. O. Ouma, et al. 2009. Performance of malaria rapid diagnostic tests as part of routine malaria case management in Kenya. Am J Trop Med Hyg 80 (3):470-74.
112. de Vries, P. J., P. A. Kager, and M. W. Borgdorff. 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363 (9415):1161.
113. Diamond, J. 2002. Evolution, consequences and future of plant and animal domestication. Nature 418 (6898):700-707.
114. Dineva, M. A., D. Candotti, F. Fletcher-Brown, J. P. Allain, and H. Lee. 2005. Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 43 (8):4015-21.
115. Djibo, S., B. M. Njanpop Lafourcade, P. Boisier, et al. 2006. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135. Trans R Soc Trop Med Hyg 100 (6):573-78.
116. Djimde, A., C. V. Plowe, S. Diop, A. Dicko, T. E. Wellems, and O. Doumbo. 1998. Use of antimalarial drugs in Mali: Policy versus reality. Am J Trop Med Hyg 59 (3):376-79.
117. Dodd, R. 1996. Patients sue "AIDS-cure" Kenyan scientist. Lancet 347 (9016):1688.
118. Domagk, G. 1935. Ein beitrag zur chemotherapie du bakteriellen infektionen. Deutsche medizinische Wochenschrift 61:250-53.
119. Dowdy, D. W., R. E. Chaisson, G. Maartens, E. L. Corbett, and S. E. Dorman. 2008. Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci 105 (32):11293-98.
120. Drakeley, C., R. Gosling, and H. Reyburn. 2005. Malaria diagnosis and treatment: One size does not fit all. PLoS Med 2 (6):e156; author reply, e165.
121. Drosten, C., S. Gottig, S. Schilling, et al. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by realtime reverse transcription-PCR. J. Clin. Microbiol. 40 (7):2323-30.
122. Durrhelm, D. N., P. J. Becker, K. Billinghurst, and A. Brink. 1997. Diagnostic disagreement- the lessons learnt from malaria diagnosis in Mpumalanga. S Afr Med J 87 (5):609-11.
123. Duse, A. G. 2008. Taking molecular and other diagnostic platforms into Africa. Presented at American Society for Microbiology 108th general meeting. Session 203: Special interest symposium. Infectious diseases in the developing world: Fostering international scientific exchange.
124. Ebola haemorrhagic fever in Zaire, 1976. 1978. Bull World Health Organ 56 (2):271-93.
125. Ebola-the plague fighters. 1996. NOVA documentary film, PBS.
126. Editors, PLoS Medicine. 2006. What are the priorities in malaria research? PLoS Med 3 (1):e83.
127. Ehrlich, Paul. 1908. Modern chemotherapy. (Ueber moderne chemoterapie: Vortrag gehalten in der X; Tagung der Deutschen Dermatologischen Gesellschaft). In Milestones in microbiology, edited by T. D. Brock. Washington, D.C.: ASM Press.
128. Ehrlich, Paul. 1909. Ueber moderne chemoterapie: Vortrag gehalten in der X; Tagung der Deutschen Dermatologischen Gesellschaft. In Beitrage zur experimentellen pathologie und chemoterapie. Leipzig: Akademische Verlagsgesellschaft.
129. El Tahir, B. M. 1977. The haemorrhagic fever outbreak in Maridi, western equatoria, southern Sudan. Paper read at Ebola Virus Haemorrhagic Fever conference, Antwerp, Belgium.
130. Elujoba, A. A., O. Fadairo, and O. O. Irinoye. 2002. Sexually transmitted diseases (STD) and HIV/AIDS in the hands of traditional medicine practitioners in Ile- Ife: Diagnoses and treatment modalities. Ife: Journal of the Insititute of Cultural Studies (8):40-54.
131. English, M., H. Reyburn, C. Goodman, and R. W. Snow. 2009. Abandoning presumptive antimalarial treatment for febrile children aged less than five years-a case of running before we can walk? PLoS Med 6 (1):e1000015.
132. Enwere, G., E. Biney, Y. B. Cheung, et al. 2006. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 25 (8):700-705.
133. Ericsson, H. M., and J. C. Sherris. 1971. Antibiotic sensitivity testing: Report of an international collaborative study. Acta Pathol Microbiol Scand [B] Microbiol Immunol 217:Suppl 217.
134. Etuk, S. J., I. H. Itam, and E. E. Asuquo. 1999. Role of the spiritual churches in antenatal clinic default in Calabar, Nigeria. East Afr Med J 76 (11):639-43.
135. Evans, J. A., A. Adusei, C. Timmann, et al. 2004. High mortality of infant bacteraemia clinically indistinguishable from severe malaria. Quart J Med 97 (9):591-97.
136. Everett, D. B., K. J. Baisely, R. McNerney, et al. 2010. Association of schistosomiasis with false positive HIV test results in an African adolescent population. J. Clin. Microbiol 48 (5):1570-77.
137. Ewald, P. 2007. A new golden age of medicine. In What is your dangerous idea? Today's leading thinkers on the unthinkable, ed. J. Brockman, 84-89. New York: HarperCollins.
138. Fadeel, M. A., J. A. Crump, F. J. Mahoney, et al. 2004. Rapid diagnosis of typhoid fever by enzyme-linked immunosorbent assay detection of Salmonella serotype Typhi antigens in urine. Am J Trop Med Hyg 70 (3):323-28.
139. Farcas, G. A., R. Soeller, K. Zhong, A. Zahirieh, and K. C. Kain. 2006. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin Infect Dis 42 (5):622-67.
140. Farmer, P., J. Furin, J. Bayona, et al. 1999. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis 3 (8):643-45.
141. Farmer, Paul. 1999. Infections and inequalities: The modern plagues. Berkeley: University of California Press.
142. Farmer, Paul. 2004. Pathologies of power: Health, human rights, and the new war on the poor. With a new preface by the author, California series in public anthropology 4. Berkeley: University of California Press.
143. Feary, D. J., D. Hyatt, J. Traub-Dargatz, et al. 2005. Investigation of falsely reported resistance of Streptococcus equi subsp. zooepidemicus isolates from horses to trimethoprim-sulfamethoxazole. J Vet Diagn Invest 17 (5):483-86.
144. Feglo, P. K., E. H. Frimpong, and M. Essel-Ahun. 2004. Salmonellae carrier status of food vendors in Kumasi, Ghana. East Afr Med J 81 (7):358-61.
145. Feierman, Steven, John M. Janzen, and Joint Committee on African Studies. 1992. The social basis of health and healing in Africa. Comparative studies of health systems and medical care no. 30. Berkeley: University of California Press.
146. Feldman, Burton. 2000. The Nobel Prize: A history of genius, controversy, and prestige. New York: Arcade.
147. Ferguson, Niall. 2007. Independence? Try "aid-dependence." Colonialism didn't cause Africa's problems, and aid alone won't fix them. L.A. Times, March 11.
148. Fichet-Calvet, E., and D. J. Rogers. 2009. Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis 3 (3):e388.
149. Fisher-Hoch, S. P., O. Tomori, A. Nasidi, et al. 1995. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice. Brit Med J 311 (7009):857-59.
150. Fleming, A. 1929. On the antibacterial action of cultures of a Penicillium, with a special reference to their use in the isolation of B. influenzae. Brit. J. Exp. Path. 10:226-36.
151. Foege, W. H. 2002. Infectious diseases. In Critical issues in global health, edited by C. Koop, C. Pearson, and M. Schwarz. San Francisco: Jossey-Bass.
152. Ford, N., E. Mills, and A. Calmy. 2009. Rationing antiretroviral therapy in Africa- treating too few, too late. N Engl J Med 360 (18):1808-10.
153. Foster, K. R., and H. Grundmann. 2006. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med 3 (2):e29.
154. Frame, J. D., J. M. Baldwin, Jr., D. J. Gocke, and J. M. Troup. 1970. Lassa fever, a new virus disease of man from West Africa: I. Clinical description and pathological findings. Am J Trop Med Hyg 19 (4):670-76.
155. Francesconi, P., Z. Yoti, S. Declich, et al. 2003. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 9 (11):1430-37.
156. Frege, G. 1980. The foundations of arithmetic: A logico-mathematical enquiry into the concept of number. Evanston, Ill.: Northwestern University Press.
157. Fuller, John Grant. 1974. Fever: The hunt for a new killer virus. London: Hart-Davis MacGibbon.
158. Gallup, J. L., and J. D. Sachs. 2001. The economic burden of malaria. Am J Trop Med Hyg 64 (1-2 Suppl):85-96.
159. Gandhi, N. R., A. Moll, A. W. Sturm, et al. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 (9547):1575-80.
160. Garrett, L. 2001. Understanding media's response to epidemics. Public Health Rep 116 Suppl 2:87-91.
161. Garrett, Laurie. 1994. The coming plague: Newly emerging diseases in a world out of balance. New York: Farrar, Straus and Giroux.
162. Gaskell, Elizabeth Cleghorn. 1866. Wives and daughters: A novel. New York: Harper & brothers.
163. Geary, T. G. 2005. Ivermectin 20 years on: Maturation of a wonder drug. Trends Parasitol 21 (11):530-32.
164. Geissler, P. W., A. Kelly, B. Imoukhuede, and R. Pool. 2008. "He is now like a brother, I can even give him some blood"-relational ethics and material exchanges in a malaria vaccine "trial community" in The Gambia. Soc Sci Med 67 (5):696-707.
165. Gicquelais, K. G., M. M. Baldini, J. Martinez, et al. 1990. Practical and economical method for using biotinylated DNA probes with bacterial colony blots to identify diarrhea-causing Escherichia coli. J Clin Microbiol 28 (11):2485-90.
166. Gillis, Justin. 2005. Lives lost as vaccine programs face delays, efforts to get medicine to poor children falter. Washington Post, A01.
167. Gisselquist, D., J. J. Potterat, S. Brody, and S. F. Minkin. 2004. Does selected ecological evidence give a true picture of HIV transmission in Africa? Int J STD AIDS 15 (7):434-39.
168. Gisselquist, D., R. Rothenberg, J. Potterat, and E. Drucker. 2002. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int J STD AIDS 13 (10):657-66.
169. Goodman, C., W. Brieger, A. Unwin, A. Mills, S. Meek, and G. Greer. 2007. Medicine sellers and malaria treatment in sub-Saharan Africa: What do they do and how can their practice be improved? Am J Trop Med Hyg 77 (6 Suppl):203-18.
170. Gordon, S. B., S. Kanyanda, A. L. Walsh, et al. 2003. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 9 (6):747-49.
171. Grabowsky, M. 2008. The billion-dollar malaria moment. Nature 451 (7182):1051-52.
172. Graham, S. M., and M. English. 2009. Non-typhoidal salmonellae: A management challenge for children with community-acquired invasive disease in tropical African countries. Lancet 373 (9659):267-69.
173. Granich, R. M., C. F. Gilks, C. Dye, K. M. De Cock, and B. G. Williams. 2008. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet 373 (9657):48-57.
174. Griner, P. F., and R. J. Glaser. 1982. Sounding boards: Misuse of laboratory tests and diagnostic procedures. N Engl J Med 307 (21):1336-39.
175. Groopman, Jerome E. 2007. How doctors think. Boston: Houghton Mifflin.
176. Guerrant, R. L., R. Oria, O. Y. Bushen, P. D. Patrick, E. Houpt, and A. A. Lima. 2005. Global impact of diarrheal diseases that are sampled by travelers: The rest of the hippopotamus. Clin Infect Dis 41 Suppl 8:S524-30.
177. Guimard, Y., M. A. Bwaka, R. Colebunders, et al. 1999. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179 Suppl 1:S268-73.
178. Guyon, A. B., A. Barman, J. U. Ahmed, A. U. Ahmed, and M. S. Alam. 1994. A baseline survey on the use of drugs at the primary health care level in Bangladesh. Bulletin WHO 72:265-71.
179. Gwer, S., C. R. Newton, and J. A. Berkley. 2007. Over-diagnosis and co-morbidity of severe malaria in African children: A guide for clinicians. Am J Trop Med Hyg 77 (6 Suppl):6-13.
180. Hamer, D. H., M. Ndhlovu, D. Zurovac, et al. 2007. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 297 (20):2227-31.
181. Hampton, J. R., M. J. Harrison, J. R. Mitchell, J. S. Prichard, and C. Seymour. 1975. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 2 (5969):486-89.
182. Harrison, L. H., V. Simonsen, and E. A. Waldman. 2008. Emergence and disappearance of a virulent clone of Haemophilus influenzae biogroup aegyptius, cause of Brazilian purpuric fever. Clin Microbiol Rev. 21(4):594-605.
183. Hatta, Mochammad, and Henk L. Smits. 2007. Detection of Salmonella Typhi by nested polymerase chain reaction in blood, urine, and stool samples. Am J Trop Med Hyg 76 (1):139-43.
184. Helfand, R. F., W. J. Moss, R. Harpaz, S. Scott, and F. Cutts. 2005. Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ 83 (5):329-37.
185. Hennessy, T. W., R. Marcus, V. Deneen, et al. 2004. Survey of physician diagnostic practices for patients with acute diarrhea: Clinical and public health implications. Clin Infect Dis 38 Suppl 3:S203-11.
186. Hill, P. C., C. O. Onyeama, U. N. Ikumapayi, et al. 2007. Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infect Dis 7:2.
187. Hoffman, S. L. 2000. Infectious disease: Research (genomics) is crucial to attacking malaria. Science 290 (5496):1509.
188. Holmes, E. C. 1998. Molecular epidemiology and evolution of emerging infectious diseases. Br Med Bull 54 (3):533-43.
189. Holmes, G. P., J. B. McCormick, S. C. Trock, et al. 1990. Lassa fever in the United States: Investigation of a case and new guidelines for management. N Engl J Med 323 (16):1120-23.
190. Hopkins, D. R. 1976. After smallpox eradication: Yaws? Am J Trop Med Hyg 25 (6):860-65.
191. Hopkins, H., C. Asiimwe, and D. Bell. 2009. Access to antimalarial therapy: Accurate diagnosis is essential to achieving long term goals. Br Med J 339:b2606.
192. Howie, S. R., M. Antonio, A. Akisanya, et al. 2007. Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine. Vaccine 25 (34):6305-09.
193. Huang, Y. F., and N. Q. Lu. 2005. [Jeremiah Abalaka and his HIV vaccine]. Zhonghua Nan Ke Xue 11 (1):7-8.
194. Hughes, J. M., C. J. Peters, M. L. Cohen, and B. W. Mahy. 1993. Hantavirus pulmonary syndrome: An emerging infectious disease. Science 262 (5135):850-51.
195. Hull, H. F., and R. B. Aylward. 1999. The scientific basis for stopping polio immunization. Am J Epidemiol 150 (10):1022-1025.
196. Hunt, Nancy Rose. 1999. A colonial lexicon of birth ritual, medicalization, and mobility in the Congo. Durham, N.C.: Duke University Press.
197. Ibadin, M. O., and A. Ogbimi. 2004. Antityphoid agglutinins in African school aged children with malaria. West Afr J Med 23 (4):276-79.
198. Idris, A. A., and N. Idris. 2006. Personal experience: Overview of Sudan's experience with Ebola hemorhagic fever (1976). Sudanese Journal of Public Health 1 (1):49-55.
199. Ihekweazu, C., I. Anya, and E. Anosike. 2005. Nigerian medical graduates: Where are they now? Lancet 365 (9474):1847-48.
200. IID (Intestinal Infectious Disease), Study Team. 2000. A report of the study of infectious intestinal disease in England. London: Foodstandards Agency.
201. Iliffe, John. 2006. The African AIDS epidemic: A history. Oxford: James Currey; Athens: Ohio University Press.
202. Inegbenebor, U., J. Okosun, and J. Inegbenebor. 2010. Prevention of Lassa fever in Nigeria. Trans R Soc Trop Med Hyg 104 (1):51-54.
203. Institute of Medicine (U.S.), Committee for the Study on Malaria Prevention and Control: Status Review and Alternative Strategies, and S. C. Oaks. 1991. Malaria: Obstacles and opportunities; a report of the Committee for the Study on Malaria Prevention and Control; Status Review and Alternative Strategies, Division of International Health, Institute of Medicine. Washington, D.C.: National Academy Press.
204. Iriemenam, N. C., W. A. Oyibo, and A. F. Fagbenro-Beyioku. 2008. Dracunculiasis- the saddle is virtually ended. Parasitol Res 102 (3):343-47.
205. Ishengoma, D. R., R. T. Rwegoshora, K. Y. Mdira, et al. 2009. Health laboratories in the Tanga region of Tanzania: The quality of diagnostic services for malaria and other communicable diseases. Ann Trop Med Parasitol 103 (5):441-53.
206. Izugbara, C. O., and A. I. Afangideh. 2005. Urban< women's use of rural-based health care services: The case of Igbo women in Aba City, Nigeria. J Urban Health 82 (1):111-21.
207. Jacquet, D, M. Boelaert, J. Seaman, et al. 2006. Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health 11 (12):1777-84.
208. Jelinek, T., M. P. Grobusch, and G. Harms. 2001. Evaluation of a dipstick test for the rapid diagnosis of imported malaria among patients presenting within the network TropNetEurop. Scand J Infect Dis 33 (10):752-54.
209. Jelinek, T., M. P. Grobusch, S. Schwenke, et al. 1999. Sensitivity and specificity of dipstick tests for rapid diagnosis of malaria in nonimmune travelers. J Clin Microbiol 37 (3):721-23.
210. Jenner, Edward. 1798. An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some western counties of England, particularly Gloucestershire, and known by the name of The Cow Pox. Reprinted in Milestones in Microbiology 1546-1940, edited by T. D. Brock, 121-25. Washington, D.C.: ASM Press, 1999.
211. Johnson, K. M., P. A. Webb, and D. L. Heymann. 1978. Evaluation of the plasmapheresis program in Zaire. In Ebola virus hemorrhagic fever, edited by S. R. Pattyn. Amsterdam: Elsevier/North-Holland Biomedical Press.
212. Johnson, R., A. M. Jordaan, R. Warren, et al. 2008. Drug susceptibility testing using molecular techniques can enhance tuberculosis diagnosis. J Infect Dev Ctries 2 (1):40-45.
213. Jones, K. D., T. Hesketh, and J. Yudkin. 2008. Extensively drug-resistant tuberculosis in sub-Saharan Africa: An emerging public-health concern. Trans R Soc Trop Med Hyg 102 (3):219-24.
214. Jones, K. E., N. G. Patel, M. A. Levy, et al. 2008. Global trends in emerging infectious diseases. Nature 451 (7181):990-93.
215. Jordan, T. 2001. British contributions to medical research and education in Africa after the Second World War. In Wellcome Witness Seminar 10: British contributions to medical research and education in Africa after the Second World War. L. Reynolds and E. Tansey, eds. London: The Wellcome Trust.
216. Kariuki, S., G. Revathi, N. Kariuki, J. Kiiru, J. Mwituria, and C. A. Hart. 2006. Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol 6:101.
217. Kazatchkine, M. 2007. The Global Fund expands its role: Interview by the Bulletin. Bull World Health Organ 85 (10):742-43.
218. Kebede, A., and A. M. Polderman. 2004. Etiology of acute diarrhea in adults in southwestern Nigeria. J Clin Microbiol 42 (8):3909; author reply, 3909-10.
219. Kennedy, Pagan. 2003. Necessity is the mother of invention. New York Times, November 30.
220. Kernéis, Solen, Lamine Koivogui, N'Faly Magassouba, et al. 2009. Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: A cross-sectional study. PLoS Negl Trop Dis 3 (11):e548.
221. Khan, A. S., A. Sanchez, and A. K. Pflieger. 1998. Filoviral haemorrhagic fevers. Br Med Bull 54 (3):675-92.
222. Khan, A. S., F. K. Tshioko, D. L. Heymann, et al. 1999. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179 Suppl 1:S76-86.
223. Khan, S. H., A. Goba, M. Chu, et al. 2008. New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78 (1):103-15.
224. Kim, J. Y. 2005. Jim Yong Kim-WHO HIV/AIDS director: Interviewed by Pam Das. Lancet Infect Dis 5 (9):544-47.
225. Kim, J. Y., and C. Gilks. 2005. Scaling up treatment-why we can't wait. N Engl J Med 353 (22):2392-94.
226. Kiple, Kenneth F. 1993. The Cambridge world history of human disease. Cambridge: Cambridge University Press.
227. Kirkland, D. 2003. Preliminary findings on the socio-economic impact of Lassa fever in Sierra Leone. Lassa Fever Update (February), 16.
228. Koch, Robert. 1876. Die Aetiologie der Mizbrand-Krakheit, begründet auf die Entwicklungsgeschichte des Bacillus Anthracis. Beiträge zur Biologie der Pflanzen 2 (2):277-310.
229. Koch, Robert. 1880. Investigations into the etiology of traumatic infective diseases. In Milestones in Microbiology 1546-1940, edited by T. D. Brock. Washington, D.C.: ASM Press.
230. Koch, Robert. 1881. Zur Untersuchung von Pathogenen Organismen. Mittheilungen aus dem Kaiserlichen Gesundheitsamte 1:1-48.
231. Koch, Robert. 1882. Die ätiologie der tuberkulose. Berliner Klinischen Wochenschrift 15:221-30.
232. Koch, Robert. 1884. Die Aetiologie der tuberculose. Mittheilungen aus dem Kaiserlichen Gesundheitsamte 2:1-88.
233. Korenromp, E. L., J. Miller, R. E. Cibulskis, M. Kabir Cham, D. Alnwick, and C. Dye. 2003. Monitoring mosquito net coverage for malaria control in Africa: Possession vs. use by children under 5 years. Trop Med Int Health 8 (8): 693-703.
234. Koukounari, A., J. P. Webster, C. A. Donnelly, et al. 2009. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am J Trop Med Hyg 80 (3):435-41.
235. Kvalsund, M. P., A. Haworth, D. L. Murman, E. Velie, and G. L. Birbeck. 2009. Closing gaps in antiretroviral therapy access: Human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers. Am J Trop Med Hyg 80 (6):1054-59.
236. Kwena, Z. A. 2004. Politics, etiquette and the fight against HIV/AIDS in Kenya: Negotiating a common front. Africa Development 29 (4):113-31.
237. Laboratory support for poliomyelitis eradication: Memorandum from a WHO meeting. 1989. Bull World Health Organ 67 (4):365-67.
238. Lamunu, M., J. J. Lutwama, J. Kamugisha, A. Opio, and J. Nambooze. 2002. Containing hemorrhagic fever epidemic, the Ebola experience in Uganda (October 2000-January 2001). Paper read at 10th International Congress on Infectious Disease, Singapore.
239. Lantin, J. P., R. Peitrequin, and P. C. Frei. 1987. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: Sensitivity and specificity of commercial tests. Int Arch Allergy Appl Immunol 82 (3-4):487-89.
240. Larsen, C. H. 2008. The fragile environments of inexpensive CD4+ T-cell enumeration in the least developed countries: Strategies for accessible support. Cytometry B Clin Cytom 74 Suppl 1:S107-16.
241. Lassa Fever-Nigeria (05). 2009. Promed, 5 March.
242. Lawn, J. E., S. Cousens, and J. Zupan. 2005. 4 million neonatal deaths: When? Where? Why? Lancet 365 (9462):891-900.
243. Lawn, S. D., B. Afful, and J. W. Acheampong. 1998. Pulmonary tuberculosis: Diagnostic delay in Ghanaian adults. Int J Tuberc Lung Dis 2 (8):635-40.
244. Leach, A., T. F. McArdle, W. A. Banya, et al. 1999. Neonatal mortality in a rural area of The Gambia. Ann Trop Paediatr 19 (1):33-43.
245. Leader, A., and A. Snyder. 2006. Essays in public health and preventive medicine: History and health care in Angola. Mt Sinai J Med 73 (2):567-68.
246. Leavitt, Judith Walzer. 1996. Typhoid Mary: Captive to the public's health. Boston: Beacon Press.
247. Le Fanu, James. 2000. The rise and fall of modern medicine. New York: Carroll and Graf.
248. Leroy, E. M., S. Baize, C. Y. Lu, et al. 2000. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 60 (4):463-67.
249. Leroy, E. M., A. Epelboin, V. Mondonge, et al. 2009. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 9 (6):723-28.
250. Leroy, E. M., B. Kumulungui, X. Pourrut, et al. 2005. Fruit bats as reservoirs of Ebola virus. Nature 438 (7068):575-76.
251. Leroy, E. M., P. Rouquet, P. Formenty, et al. 2004. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303 (5656):387-90.
252. Leroy, E. M., P. Telfer, B. Kumulungui, et al. 2004. A serological survey of Ebola virus infection in central African nonhuman primates. J Infect Dis 190 (11):1895-99.
253. Levine, Ruth. 2004. Millions saved: Proven successes in global health. Washington, D.C.: Center for Global Development.
254. Levy, S. B. 2002. The antibiotic paradox: How the misuse of antibiotics destroys their curative power. Cambridge: Perseus.
255. Lienhardt, C., J. Rowley, K. Manneh, et al. 2001. Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: The experience of The Gambia. Int J Tuberc Lung Dis 5 (3):233-39.
256. Lin, M., B. Dong, Z. Tang, et al. Analysis of data on surveillance of typhoid and paratyphoid fever in Guangxi 2000-2004. Paper read at 6th International Conference on Typhoid Fever and Other Salmonelloses, Guilin, China.
257. Lister, Joseph. 1878. On the lactic fermentation and its bearings on pathology. Transactions of the Pathological Society of London 29:425-67.
258. Lubell, Y., H. Reyburn, H. Mbakilwa, et al. 2007. The cost-effectiveness of parasitologic diagnosis for malaria-suspected patients in an era of combination therapy. Am J Trop Med Hyg 77 (6 Suppl):128-32.
259. Lubell, Y., H. Reyburn, H. Mbakilwa, et al. 2008. The impact of response to the results of diagnostic tests for malaria: Costbenefit analysis. Br Med J 336 (7637):202-5.
260. Luchavez, J., M. E. Lintag, M. Coll-Black, F. Baik, and D. Bell. 2007. An assessment of various blood collection and transfer methods used for malaria rapid diagnostic tests. Malaria J 6 (1):149.
261. Lundqvist, T., S. L. Fisher, G. Kern, et al. 2007. Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447 (7146):817-22.
262. Mabey, D., R. W. Peeling, A. Ustianowski, and M. D. Perkins. 2004. Diagnostics for the developing world. Nat Rev Microbiol 2 (3):231-40.
263. Magnaval, J. F., A. Berry, R. Fabre, and S. Cassaing. 2006. Plasmodium falciparum chloroquine-resistance transporter gene detection in imported Plasmodium falciparum malaria cases. Clin Infect Dis 42 (12):1806-7.
264. Makler, M. T., C. J. Palmer, and A. L. Ager. 1998. A review of practical techniques for the diagnosis of malaria. Ann Trop Med Parasitol 92 (4):419-33.
265. Makundi, E. A., L. E. Mboera, H. M. Malebo, and A. Y. Kitua. 2007. Priority setting on malaria interventions in Tanzania: Strategies and challenges to mitigate against the intolerable burden. Am J Trop Med Hyg 77 (6 Suppl):106-11.
266. Mandomando, I. M., E. V. Macete, J. Ruiz, et al. 2007. Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. Am J Trop Med Hyg 76 (3):522-27.
267. Marburg hemorrhagic fever-Angola (46). 2005. Promed, 30 May.
268. Marx, A., J. D. Glass, and R. W. Sutter. 2000. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 22 (2):298-316.
269. Masiye, F., N. Kass, A. Hyder, P. Ndebele, and J. Mfutso-Bengo. 2008. Why mothers choose to enroll their children in malaria clinical studies and the involvement of relatives in decision making: Evidence from Malawi. Malawi Med J 20 (2):50-56.
270. Masiye, F., and C. Rehnberg. 2005. The economic value of an improved malaria treatment programme in Zambia: Results from a contingent valuation survey. Malar J 4:60.
271. Mason, C. 2008. The strains of Ebola. Canad Med Assoc J 178 (10):1266-67.
272. Masum, H., A. S. Daar, S. Al-Bader, R. Shah, and P. A. Singer. 2007. Accelerating health product innovation in sub-Saharan Africa. Innovations 2 (4):129-49.
273. Mathebula, Nsovo S., Jeseelan Pillay, Gianna Toschi, Jan A. Verschoor, and Kenneth I. Ozoemena. 2009. Recognition of anti-mycolic acid antibody at self-assembled mycolic acid antigens on a gold electrode: A potential impedimetric immunosensing platform for active tuberculosis. Chem Commun (23):3345-47.
274. Mboera, L. E., E. A. Makundi, and A. Y. Kitua. 2007. Uncertainty in malaria control in Tanzania: Crossroads and challenges for future interventions. Am J Trop Med Hyg 77 (6 Suppl):112-18.
275. Mboya-Okeyo, T., R. G. Ridley, and S. Nwaka. 2009. The African Network for Drugs and Diagnostics Innovation. Lancet 373 (9674):1507-8.
276. McCormick, J. B., I. J. King, P. A. Webb, et al. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155 (3):445-55.
277. McElroy, P. D., A. A. Lal, W. A. Hawley, et al. 1999. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg 61 (6):932-40.
278. McLean, A. R. 1998. Vaccines and their impact on the control of disease. Br Med Bull 54 (3):545-56.
279. Mda, Z. 2007. Cion: A novel. New York: Picador.
280. Meda, N., I. Ndoye, S. M'Boup, et al. 1999. Low and stable HIV infection rates in Senegal: Natural course of the epidemic or evidence for success of prevention? AIDS 13 (11):1397-405.
281. Mellor, Nicholas. 2004. Obituary: Dr Aniru Conteh-Lassa fever specialist who became an icon to relief workers. Independent, 9 April.
282. Mengara, Daniel. 2005. Contagion and containment in the African mind: A cultural approach to disease in Africa. Paper read at Africa Conference 2005: African Health and Illness, Austin, Texas.
283. Mensah, P., R. Noora, J. Welbeck, and P. K. Nyame. 2000. Laboratory diagnosis of typhoid fever in Accra. Ghana Med J 34 (2):67-70.
284. Mfutso-Bengo, J., F. Masiye, M. Molyneux, P. Ndebele, and A. Chilungo. 2008. Why do people refuse to take part in biomedical research studies? Evidence from a resource-poor area. Malawi Med J 20 (2):57-63.
285. Michel, C. E., A. W. Solomon, J. P. Magbanua, et al. 2006. Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: A comparative study. Lancet 367 (9522):1585-90.
286. Miles, S. H. 2003. HIV in insurgency forces in sub-Saharan Africa-a personal view of policies. Int J STD AIDS 14 (3):174-78.
287. Miller, P., and M. Bohnhoff. 1950. The development of bacterial resistance to chemotherapeutic agents. Ann Rev Microbiol 4:201-22.
288. Million, R. P. 2006. Impact of genetic diagnostics on drug development strategy. Nat Rev Drug Discov 5 (6):459-62.
289. Minor, P. D. 2004. Polio eradication, cessation of vaccination and re-emergence of disease. Nat Rev Microbiol 2 (6):473-82.
290. Minot, G. R., and W. P. Murphy. 1926. Treatment of pernicious anemia by a special diet. JAMA 87:470-76.
291. Mirza, N. B. 1995. Diagnosis and over diagnosis of typhoid fever. East Afr Med J 72 (12):753-54.
292. Mitiku, K., G. Mengistu, and B. Gelaw. 2003. The reliability of blood film examination for malaria at the peripheral health unit. Ethiop J Health Dev 17 (3):197-204.
293. Molyneux, D. H., D. R. Hopkins, and N. Zagaria. 2004. Disease eradication, elimination and control: The need for accurate and consistent usage. Trends Parasitol 20 (8):347-51.
294. Monath, T. P. 1975. Lassa fever: Review of epidemiology and epizootiology. Bull World Health Organ 52 (4-6):577-92.
295. Monath, T. P. 1999. Ecology of Marburg and Ebola viruses: Speculations and directions for future research. J Infect Dis 179 Suppl 1:S127-38.
296. Moore, M. R., R. E. Gertz, Jr., R. L. Woodbury, et al. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197 (7):1016-27.
297. Msellem, M. I., A. Martensson, G. Rotllant, et al. 2009. Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: A crossover validation study. PLoS Med 6 (4):e1000070.
298. Mtove, G., B. Amos, L. von Seidlein, et al. 2010. Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One 5 (2):e9244.
299. Mugyenyi, P., A. S. Walker, J. Hakim, et al. 2010. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): A randomised non-inferiority trial. Lancet 375 (9709):123-31.
300. Mulholland, E. K., O. O. Ogunlesi, R. A. Adegbola, et al. 1999. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 18 (10 Suppl):S35-41.
301. Murphy, S. C., and J. G. Breman. 2001. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64 (1-2 Suppl):57-67.
302. Murray, C. J., and A. D. Lopez. 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (9063):1436-42.
303. Murru, M. 2004. AIDS, primary health care and poverty. Health Policy and Development 2 (1):1-12.
304. Musher, D. M. 2006. Pneumococcal vaccine-direct and indirect ("herd") effects. N Engl J Med 354 (14):1522-24.
305. Mutanda, L. N., A. M. Omari, and I. A. Wamola. 1989. Adaptation of a method of measuring zone diameters of bacterial growth inhibition by antibiotics to suit developing countries. East Afr Med J 66 (7):441-47.
306. Muula, A. S., and F. C. Maseko. 2006. Medical laboratory services in Africa deserve more. Clin Infect Dis 42 (10):1503.
307. Muyembe-Tamfum, J. J., M. Kipasa, C. Kiyungu, and R. Colebunders. 1999. Ebola outbreak in Kikwit, Democratic Republic of the Congo: Discovery and control measures. J Infect Dis 179 Suppl 1:S259-62.
308. Mwanziva, C., S. Shekalaghe, A. Ndaro, et al. 2008. Overuse of artemisinin-combination therapy in Mto wa Mbu (river of mosquitoes), an area misinterpreted as high endemic for malaria. Malar J 7:232.
309. Nabarro, D. 1999. Roll Back Malaria. Parassitologia 41 (1-3):501-04.
310. Nabarro, D. N., and E. M. Tayler. 1998. The "roll back malaria" campaign. Science 280 (5372):2067-68.
311. Naheed, A., P. K. Ram, W. A. Brooks, et al. 2008. Clinical value of Tubex and Typhidot rapid diagnostic tests for typhoid fever in an urban community clinic in Bangladesh. Diagn Microbiol Infect Dis 61 (4):381-86.
312. Nahlen, B. L., E. L. Korenromp, J. M. Miller, and K. Shibuya. 2005. Malaria risk: Estimating clinical episodes of malaria. Nature 437 (7056):e3; discussion, e4-5.
313. NCCLS, National Committee on Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd edition; Approved standard. Villanova, Penn.: National Committee for Clinical Laboratory Standards.
314. NCCLS, National Committee on Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests, 8th edition; Approved standard. Villanova, Penn.: National Committee for Clinical Laboratory Standards.
315. Needham, Cynthia. 2000. Intimate strangers: Unseen life on Earth. Washington, D.C.: ASM Press.
316. Needham, Cynthia, and Richard Canning. 2003. Global disease eradication: The race for the last child. Washington, D.C.: ASM Press.
317. Needham, D. M., S. D. Foster, G. Tomlinson, and P. Godfrey-Faussett. 2001. Socio-economic, gender and health services factors affecting diagnostic delay for tuberculosis patients in urban Zambia. Trop Med Int Health 6 (4):256-59.
318. Neil, K., S. Sodha, L. Luswago, et al. 2009. Outbreak of typhoid fever with high rate of intestinal perforation, Kasese District, Uganda-2008-2009. Am J Trop Med Hyg 81 (5 Suppl 1):330S.
319. Newman, M. J., E. Frimpong, A. Asamoah-Adu, E. Sampane-Donkor, and J. A. Opintan. 2004. Resistance to antimicrobial drugs in Ghana. Ghanaian-Dutch Collaboration for Health Research and Development.
320. Nicholls, H. 2005. Combating tuberculosis. Wellcome Focus: Antibiotic resistance-an unwinnable war?, 31.
321. Nkrumah, Kwame. 1963. The Academy of Sciences dinner, after dinner speech. November 30, 1963, at Fourth Anniversary of the Academy of Sciences, Ghana. In Selected speeches: Kwame Nkrumah. Ghana: Afram Publishers, 1997.
322. Nordstrand, A., I. Bunikis, C. Larsson, et al. 2007. Tickborne relapsing fever diagnosis obscured by malaria, Togo. Emerg Infect Dis 13 (1):117-23.
323. Norrby, S. R. 2005. Infectious disease emergencies: Role of the infectious disease specialist. Clin Microbiol Infect 11 Suppl 1:9-11.
324. Norrby, S. R., C. E. Nord, and R. Finch. 2005. Lack of development of new antimicrobial drugs: A potential serious threat to public health. Lancet Infect Dis 5 (2):115-19.
325. Nsubuga, P., S. McDonnell, B. Perkins, et al. 2002. Polio eradication initiative in Africa: Influence on other infectious disease surveillance development. BMC Public Health 2:27.
326. Nsutebu, E. F., P. Martins, and D. Adiogo. 2003. Prevalence of typhoid fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon. Trop Med Int Health 8 (6):575-78.
327. Nsutebu, E. F., P. M. Ndumbe, and D. Adiogo. 2002. The distribution of anti-Salmonella antibodies in the sera of blood donors in Yaounde, Cameroon. Trans R Soc Trop Med Hyg 96 (1):68-69.
328. Nsutebu, E. F., P. M. Ndumbe, and S. Koulla. 2002. The increase in occurrence of typhoid fever in Cameroon: Overdiagnosis due to misuse of the Widal test? Trans R Soc Trop Med Hyg 96 (1):64-67.
329. Nuland, Sherwin B. 1989. Doctor: The biography of medicine. New York: Vintage Books.
330. Nwaka, S. 2005. Drug discovery and beyond: The role of public-private partnerships in improving access to new malaria medicines. Trans R Soc Trop Med Hyg 99 Suppl 1:S20-9.
331. Nwapa, Flora. 1966. Efuru. [London]: Heinemann.
332. Obadare, E. 2005. A crisis of trust: History, politics, religion and the polio controversy in northern Nigeria. Patterns of Prejudice 39 (3):265-66.
333. Ogunbodede, E. O., M. O. Folayan, and M. A. Adedigba. 2005. Oral health-care workers and HIV infection control practices in Nigeria. Trop Doct 35 (3):147-150.
334. Ogungbamila, F. O., and A. O. Ogundaini, eds. 1993. Traditional healing methods in the control and treatment of infectious diseases. Ile-Ife, Nigeria: Antimicrobial Plant Research Group, Obafemi Awolowo Univerisity.
335. Ohrt, C., P. Obare, A. Nanakorn, et al. 2007. Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya. Malar J 6:79.
336. Ojo, O. S. 2004. "...To judge the living and the dead..." The pathologist, the misery, the mystery and the final diagnosis: An interminable quest for excellence. Inaugural Lecture Series 172. Ile-Ife, Nigeria: Obafemi Awolowo University Press.
337. Okeke, I. N. 2006. Diagnostic insufficiency in Africa. Clin Infect Dis 42 (10):1501-53.
338. Okeke, I. N. 2009. The tragedy of antimicrobial resistance: Achieving a recognition of necessity. Current Science 97 (11):1564-72.
339. Okeke, I. N., A. O. Aboderin, D. K. Byarugaba, O. Ojo, and J. A. Opintan. 2007. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis 13 (11):1640-46.
340. Okeke, I. N., and A. Lamikanra. 1995. Quality and bioavailability of tetracycline capsules in a Nigerian semi-urban community. Int J Antimicrob Ag 5:245-50.
341. Okeke, I. N., and A. Lamikanra. 2001. Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community. Afr J Med Med Sci 30 (1-2):47-51.
342. Okeke, I. N., and J. Wain. 2008. Post-genomic challenges for collaborative research in infectious diseases. Nat Rev Microbiol 6 (11):858-64.
343. Okiro, E. A., S. I. Hay, P. W. Gikandi, et al. 2007. The decline in paediatric malaria admissions on the coast of Kenya. Malar J 6:151.
344. Oldstone, Michael B. A. 1998. Viruses, plagues, and history. New York: Oxford University Press.
345. Olopoenia, L. A., and A. L. King. 2000. Widal agglutination test-100 years later: Still plagued by controversy. Postgrad Med J 76 (892):80-84.
346. Olukoya, P., and J. Ferguson. 2003. Olikoye Ransome-Kuti. Lancet 362:175.
347. Omura, S., and A. Crump. 2004. The life and times of ivermectin-a success story. Nat Rev Microbiol 2 (12):984-89.
348. Opintan, J. A., and M. J. Newman. 2007. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Med J 41 (1):4-8.
349. Orji, J. N. 1982. A re-assessment of the organisation and benefits of the slave and palm produce trade amongst the Ngwa-Igbo. Canadian Journal of African Studies 16 (3):523-48.
350. Oshinsky, David M. 2005. Polio: An American story. Oxford: Oxford University Press.
351. Oshisada, Victor. 2006. The HIV-baby controversy. Editorial opinion, Guardian (Lagos), 29 June.
352. Osler, William. 1892. The principles and practice of medicine: Designed for the use of practitioners and students of medicine. New York: D. Appleton and Company.
353. O-tipo, S., K. Neil, S. Sodha, et al. 2009. Typhoid fever outbreak in Kasese District, Uganda: 103 cases with intestinal perforation. Am J Trop Med Hyg 81 (5 Suppl 1):330.
354. Outbreak news: Ebola haemorrhagic fever, Uganda-end of the outbreak. 2008. Wkly Epidemiol Rec 83 (10):89-90.
355. Outbreak of Ebola haemorrhagic fever in Yambio, south Sudan, April-June 2004. 2005. Wkly Epidemiol Rec 80 (43):370-75.
356. Packard, Randall M. 2000. Post-colonial medicine. In Medicine in the 20th century, edited by R. Cooter and J. Pickstone. Amsterdam: Harwood Academic.
357. Pai, M., J. Minion, H. Sohn, A. Zwerling, and M. D. Perkins. 2009. Novel and improved technologies for tuberculosis diagnosis: Progress and challenges. Clin Chest Med 30 (4):701-16.
358. Pai, M., and R. O'Brien. 2008. New diagnostics for latent and active tuberculosis: State of the art and future prospects. Semin Respir Crit Care Med 29 (5):560-68.
359. Pai, Madhukar, Andrew Ramsay, and Richard O'Brien. 2008. Evidence-based tuberculosis diagnosis. PLoS Med 5 (7):e156.
360. Palmer, A., M. Weber, K. Bojang, T. McKay, and R. Adegbola. 1999. Acute bacterial meningitis in The Gambia: A four-year review of paediatric hospital admissions. J Trop Pediatr 45 (1):51-53.
361. Palumbi, S. R. 2001. Humans as the world's greatest evolutionary force. Science 293 (5536):1786-90.
362. Panhotra, B. R., Z. U. Hassan, C. S. Joshi, and A. Bahrani. 2005. Visual detection of multiple viral amplicons by dipstick assay: Its application in screening of blood donors a welcome tool for limited resource settings. J Clin Microbiol 43 (12):6218; author reply, 6218-19.
363. Paramasivan, C. N., E. Lee, K. Kao, et al. 2010. Experience establishing tuberculosis laboratory capacity in a developing country setting. Int J Tuberc Lung Dis 14 (1):59-64.
364. PATH, Program for Appropriate Technology in Health. 2008. Diarrheal disease advocacy: Findings from a scan of the global funding and policy landscape. Seattle: Program for Appropriate Technology in Health.
365. Paweska, J. T. 2007. Lassa fever-South Africa ex Nigeria [Promed-MAIL] 2007 [cited 14 March].
366. Payne, D. J., M. N. Gwynn, D. J. Holmes, and D. L. Pompliano. 2007. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6 (1):29-40.
367. Peeling, R. W. 2007. Diagnostics for sexually transmitted infections. Presented in Diagnostics in the tropics-time to take the guesswork out of clinical practice. Symposium 33 in the 56th Annual meeting of the American Society for Tropical Medicine and Hygiene. Philadelphia.
368. Peeling, R. W., D. Mabey, A. Herring, and E. W. Hook. 2006. Why do we need qualityassured diagnostic tests for sexually transmitted infections? Nat Rev Microbiol 4 (12 Suppl):S7-19.
369. Pelton, S. I., A. M. Loughlin, and C. D. Marchant. 2004. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J 23 (11):1015-22.
370. Perkins, M. D., G. Roscigno, and A. Zumla. 2006. Progress towards improved tuberculosis diagnostics for developing countries. Lancet 367 (9514):942-43.
371. Perkins, M., and D. Bell. 2008. Working without a blindfold: The critical role of diagnostics in malaria control. Malaria Journal 7 (Suppl 1):S5.
372. Peters, R. P., E. E. Zijlstra, M. J. Schijffelen, et al. 2004. A prospective study of bloodstream infections as cause of fever in Malawi: Clinical predictors and implications for management. Trop Med Int Health 9 (8):928-34.
373. Peterson, A. T., D. S. Carroll, J. N. Mills, and K. M. Johnson. 2004. Potential mammalian filovirus reservoirs. Emerg Infect Dis 10 (12):2073-81.
374. Petri, R. J. 1887. Eine kleine modification des Koch'schen plattenverfahrens. Centralblatt für Bacteriologie und Parasitenkunde 1:279-80.
375. Pettersson, U., H. Wigzell, and P. Perlman. 1987. Malaria diagnosis. Science 236 (4797):11-12.
376. Petti, C. A., C. R. Polage, and D. R. Hillyard. 2006. Screening laboratory requests. Emerg Infect Dis 12 (11):1792-93.
377. Phillips, K. A., S. Van Bebber, and A. M. Issa. 2006. Diagnostics and biomarker development: Priming the pipeline. Nat Rev Drug Discov 5 (6):463-69.
378. Phillips, M., J. Kumate-Rodriguez, and F. Mota-Hernández. 1989. Costs of treating diarrhoea in a children's hospital in Mexico City. Bull World Health Organ 67 (3):273-80.
379. Phillips, R. S. 2001. Current status of malaria and potential for control. Clin. Microbiol. Rev. 14 (1):208-26.
380. Pincock, S. 2006. Bekololari Ransome-Kuti. Lancet 367:810.
381. Planche, T., and S. Krishna. 2005. The relevance of malaria pathophysiology to strategies of clinical management. Curr Opin Infect Dis 18 (5):369-75.
382. Plowe, C. V., and T. E. Wellems. 1995. Molecular approaches to the spreading problem of drug resistant malaria. Adv Exp Med Biol 390:197-209.
383. Polage, C. R., G. Bedu-Addo, A. Owusu-Ofori, et al. 2006. Laboratory use in Ghana: Physician perception and practice. Am J Trop Med Hyg 75 (3):526-31.
384. Porter, Roy. 1998. The greatest benefit to mankind: A medical history of humanity. New York: W. W. Norton.
385. Poupard, J. A., S. F. Rittenhouse, and L. R. Walsh. 1994. The evolution of antimicrobial susceptibility testing methods. In Antimicrobial susceptibility testing-critical issues for the '90s, edited by J. Poupard, L. Walsh, and B. Kleger. New York: Plenum Press.
386. Prati, Daniele. 2006. Non-sterile injections, contaminated blood, and the spread of HIV. Lancet 368 (9541):1064.
387. Preston, Richard. 1995. The hot zone. Rockland, Mass.: Wheeler Pub.
388. Priddy, F., F. Tesfaye, Y. Mengistu, et al. 2005. Potential for medical transmission of HIV in Ethiopia. AIDS 19 (3):348-50.
389. Prins, Gwyn. 1989. But what was the disease? The present state of health and healing in African studies. Past and Present 124:159-79.
390. Progress in reducing global measles deaths, 1999-2004. 2006. MMWR Morb Mortal Wkly Rep 55 (9):247-49.
391. Progress toward strengthening blood transfusion services-14 countries, 2003-2007. 2008. MMWR Morb Mortal Wkly Rep 57 (47):1273-77.
392. Rapatski, B. L., F. Suppe, and J. A. Yorke. 2005. HIV epidemics driven by late disease stage transmission. J Acquir Immune Defic Syndr 38 (3):241-53.
393. Reducing tests. 1981. Lancet 1 (8219):539-40.
394. Reyburn, H., H. Mbakilwa, R. Mwangi, et al. 2007. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: Randomised trial. Br Med J 334 (7590):403.
395. Reyburn, H., R. Mbatia, C. Drakeley, et al. 2004. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: A prospective study. Br Med J 329 (7476):1212.
396. Reyburn, H., E. Mwakasungula, S. Chonya, et al. 2008. Clinical assessment and treatment in paediatric wards in the north-east of the United Republic of Tanzania. Bull World Health Organ 86 (2):132-39.
397. Reyburn, H., J. Ruanda, O. Mwerinde, and C. Drakeley. 2006. The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J 5:4.
398. Richmond, J. K., and D. J. Baglole. 2003. Lassa fever: Epidemiology, clinical features, and social consequences. Br Med J 327 (7426):1271-75.
399. The right tools can save lives. 2006. Nature 444 (7120):681.
400. Roberts, L. 2009a. Polio eradication: Looking for a little luck. Science 323 (5915):702-5.
401. Roberts, L. 2009b. Public health: Type 2 poliovirus back from the dead in Nigeria. Science 325 (5941):660-61.
402. Roberts, L., and M. Enserink. 2007. Malaria. Did they really say... eradication? Science 318 (5856):1544-45.
403. Robottom, John. 1991. Health and Medicine 1750-1900. London: Longman.
404. Roels, T. H., A. S. Bloom, J. Buffington, et al. 1999. Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: Risk factors for patients without a reported exposure. J Infect Dis 179 Suppl 1:S92-7.
405. Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305 (5687):1124.
406. Ross, Ronald. 1905. The progress of tropical medicine. Journal of the African Society 4 (15): 271-89.
407. Rouquet, P., J. M. Froment, M. Bermejo, et al. 2005. Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis 11 (2):283-90.
408. Sachs, J. D. 2005. Achieving the Millennium Development Goals-the case of malaria. N Engl J Med 352 (2):115-17.
409. Sachs, Jeffrey. 2005. The end of poverty: Economic possibilities for our time. New York: Penguin.
410. Salmon, D. E. 1881. Investigations of swine plague and fowl cholera. In Contagious diseases of domesticated animals. Washington: U.S. Department of Agriculture.
411. Sam-Abbenyi, A., M. Dama, S. Graham, and Z. Obate. 1999. Dracunculiasis in Cameroon at the threshold of elimination. Int J Epidemiol 28 (1):163-68.
412. Santer, M. 2009. Richard Bradley: A unified, living agent theory of the cause of infectious diseases of plants, animals, and humans in the first decades of the 18th century. Perspect Biol Med 52 (4):566-78.
413. Schapira, A. 1994. A standard protocol for assessing the proportion of children presenting with febrile disease who suffer from malarial disease. World Health Organization.
414. Schmid, G. P., A. Buve, P. Mugyenyi, et al. 2004. Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet 363 (9407):482-88.
415. Schoofs, M. 1999. AIDS: The agony of Africa. Part Two: A tale of two brothers. Village Voice 44 (45):47-48, 51-52.
416. Schram, Ralph. 1971. A history of the Nigerian health services. With an introd. by Sir Samuel Manuwa. [Ibadan]: Ibadan University Press.
417. Schroeter, J. 1875. Uber einige durch bacterien gebildete pigmente (Concering a few pigments generated by bacteria). Beiträge zur Biologie der Pflanzen 1(2):109-26.
418. Science and Africa: A message to the G8 summit. 2005. Nature 435 (7046):1146-49.
419. Scott, S., W. J. Moss, S. Cousens, et al. 2007. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 45 (11):1417-24.
420. Scrimshaw, N. S. 1974. Myths and realities in international health planning. Am J Public Health 64 (8):792-98.
421. Severe acute pneumonitis among deployed U.S. military personnel-Southwest Asia. 2003. MMWR Morb Mortal Wkly Rep 52 (36):857-59.
422. Hajjeh, and David M. Bishai. 2010. Accelerating policy decisions to adopt Haemophilus influenzae Type b vaccine: A global, multivariable analysis. PLoS Med 7 (3):e1000249.
423. Shillcutt, S., C. Morel, C. Goodman, et al. 2008. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86 (2):101-10.
424. Shilts, Randy. 1988. And the band played on: Politics, people, and the AIDS epidemic. New York: Penguin Books.
425. Showstack, J. A., S. A. Schroeder, and M. F. Matsumoto. 1982. Changes in the use of medical technologies, 1972-1977: A study of 10 inpatient diagnoses. N Engl J Med 306 (12):706-12.
426. Singer, E. 2005. International partnership launches malaria model in Zambia. Nat Med 11 (7):695.
427. Singer, P. A., A. S. Daar, S. Al-Bader, et al. 2008. Commercializing African health research: Building life science convergence platforms. In Gehner, M., S. Jupp and S. A. Matlin, Global forum update on research for health volume 5: Fostering innovation for global health. Woodbridge, UK: Pro-Book Publishing.
428. Singh, J. A., R. Upshur, and N. Padayatchi. 2007. XDR-TB in South Africa: No time for denial or complacency. PLoS Med 4 (1):e50.
429. Smolinski, Mark S., Margaret A. Hamburg, Joshua Lederberg, and Institute of Medicine (U.S.). Committee on Emerging Microbial Threats to Health in the 21st Century. 2003. Microbial threats to health: Emergence, detection, and response. Washington, D.C.: National Academies Press.
430. Snow, R. W., M. H. Craig, C. R. J. C. Newton, and R. W. Steketee. 2003. The public health burden of Plasmodium falciparum malaria in Africa: Deriving the numbers. Disease Control Priorities Project Working Paper No 11. Bethesda, Maryland: Fogarty International Center, National Institutes of Health.
431. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (7030):214-17.
432. Snow, R. W., E. L. Korenromp, and E. Gouws. 2004. Pediatric mortality in Africa: Plasmodium falciparum malaria as a cause or risk? Am J Trop Med Hyg 71 (2 Suppl): 16-24.
433. Sofowora, A. 1982. Medicinal plants and traditional medicine in Africa. Chichester, West Sussex: JohnWiley.
434. Sokoloff, Boris. 1954. The miracle drugs. 3rd ed. New York: Prentice-Hall.
435. Sosa, A., D. K. Byarugaba, C. F. Amábile-Cuevas, P-R Hseuh, and I. N. Okeke, eds. 2009. Antimicrobial resistance in developing countries. New York: Springer.
436. Sow, S. O., S. Diallo, J. D. Campbell, et al. 2005. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: Impetus for routine infant immunization with conjugate vaccine. Pediatr Infect Dis J 24 (6):533-37.
437. Steen, T. W., and G. N. Mazonde. 1998. Pulmonary tuberculosis in Kweneng District, Botswana: Delays in diagnosis in 212 smear-positive patients. Int J Tuberc Lung Dis 2 (8):627-34.
438. Steketee, Richard W., Naawa Sipilanyambe, John Chimumbwa, et al. 2008. National malaria control and scaling up for impact: The Zambia experience through 2006. Am J Trop Med Hyg 79 (1):45-52.
439. Stetten, D. 1978. Victory over Variola. ASM News 44 (12):639.
440. STOP-TB, Partnership. 2006. Actions for life: Towards a world free of tuberculosis. The global plan to stop tuberculosis 2006-2015. Suit No NIC/8/2006 2008. National Industrial Court, Abuja, Nigeria.
441. Suzuki, Y., and T. Gojobori. 1997. The origin and evolution of Ebola and Marburg viruses. Mol Biol Evol 14 (8):800-806.
442. Talbot, George H., John Bradley, John E. Edwards, Jr., David Gilbert, Michael Scheld, and John G. Bartlett. 2006. Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42 (5):657-68.
443. Tan, T. Q. 2003. Antibiotic resistant infections due to Streptococcus pneumoniae: Impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 16 (3):271-77.
444. Tankhiwale, S. S., G. Agrawal, and S. V. Jalgaonkar. 2003. An unusually high occurrence of Salmonella enterica serotype paratyphi A in patients with enteric fever. Indian J Med Res 117:10-12.
445. Tapia, M. D., S. O. Sow, S. Medina-Moreno, et al. 2005. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali. Am J Trop Med Hyg 73 (1):26-31.
446. Teepe, R. G., B. K. Johnson, D. Ocheng, et al. 1983. A probable case of Ebola virus haemorrhagic fever in Kenya. East Afr Med J 60 (10):718-22.
447. Tegbaru, B., H. Meless, A. Kassu, D. Tesema, N. Gezahegn, W. Tamene, E. Hailu, H. Birhanu, and T. Messele. 2004. Laboratory services in hospitals and regional laboratories in Ethiopia. Ethiop J Health Dev 18 (1):43-47.
448. Terris-Prestholt, F., D. Watson-Jones, K. Mugeye, et al. 2003. Is antenatal syphilis screening still cost effective in sub-Saharan Africa? Sex Transm Infect 79 (5):375-81.
449. Thomas, Lewis. 1978. The lives of a cell: Notes of a biology watcher. New York: Penguin Books.
450. Thompson, L. J., S. J. Dunstan, C. Dolecek, et al. 2009. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci U S A 106 (52):22433-38.
451. Thwing, J. I., J. Mihigo, A. P. Fernandes, et al. 2009. How much malaria occurs in urban Luanda, Angola? A health facility-based assessment. Am J Trop Med Hyg 80 (3):487-91.
452. Tornheim, J. A., A. S. Manya, N. Oyando, S. Kabaka, R. F. Breiman, and D. R. Feikin. 2007. The epidemiology of hospitalized pneumonia in rural Kenya: The potential of surveillance data in setting public health priorities. Int J Infect Dis 11 (6):536-43.
453. Towner, K. J., N. J. Pearson, F. S. Mhalu, and F. O'Grady. 1980. Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ 58 (5):747-51.
454. Towner, J. S., X. Pourrut, C. G. Albarino, et al. 2007. Marburg virus infection detected in a common African bat. PLoS ONE 2 (1):e764.
455. Towner, J. S., P. E. Rollin, D. G. Bausch, et al. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78 (8):4330-41.
456. Towner, J. S., T. K. Sealy, M. L. Khristova, et al. 2008. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 4(11):e1000212.
457. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 64 (1-2 Suppl):12-17.
458. Troup, J. M., H. A. White, A. L. Fom, and D. E. Carey. 1970. An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. Am J Trop Med Hyg 19 (4):695-96.
459. Turshen, Meredeth. 1984. The political ecology of disease in Tanzania. New Brunswick, N.J.: Rutgers University Press.
460. Two accused over "fake" HIV tests. 2006. BBC News online, 30 October.
461. Twumasi, P. A. 1975. Medical systems in Ghana: A study in medical sociology. Accra: Ghana Publishing Corporation.
462. Ukwuoma, Ben. 2004. Medical lab scientists suggest measures to curb microbial drug resistance. Guardian, 11 December.
463. Ukwuoma, Ben. 2006. Council shuts 50 medical labs in Abuja, Benin. Guardian, 1 July.
464. Ulrich, M. P., D. R. Christensen, S. R. Coyne, et al. 2006. Evaluation of the Cepheid GeneXpert system for detecting Bacillus anthracis. J Appl Microbiol 100 (5):1011-16.
465. UNICEF and WHO. 2009. Diarrhoea: Why children are still dying and what can be done. UNICEF and WHO.
466. Update: International Task Force for Disease Eradication, 1990 and 1991. 1992. MMWR Morb Mortal Wkly Rep 41 (3):40-42.
467. Usdin, M., M. Guillerm, and P. Chirac. 2006. Neglected tests for neglected patients. Nature 441 (7091):283-84.
468. Uzochukwu, Benjamin, Eric Obikeze, Obinna Onwujekwe, Chima Onoka, and Ulla Griffiths. 2009. Cost-effectiveness analysis of rapid diagnostic test, microscopy and syndromic approach in the diagnosis of malaria in Nigeria: Implications for scaling-up deployment of ACT. Malar J 8 (1):265.
469. van den Brandhof, W. E., A. I. Bartelds, M. P. Koopmans, and Y. T. van Duynhoven. 2006. General practitioner practices in requesting laboratory tests for patients with gastroenteritis in the Netherlands, 2001-2002. BMC Fam Pract 7:56.
470. van Riet, E., A. A. Adegnika, K. Retra, et al. 2007. Cellular and humoral responses to influenza in Gabonese children living in rural and semi-urban areas. J Infect Dis 196 (11):1671-1678.
471. Vaughan, Megan. 1991. Curing their ills: Colonial power and African illness. Cambridge: Polity Press.
472. Verhoef, J., and A. Fluit. 2006. Surveillance uncovers the smoking gun for resistance emergence. Biochem Pharmacol 71 (7):1036-41.
473. Vila, J., J. Gascon, S. Abdalla, et al. 1994. Antimicrobial resistance of Shigella isolates causing traveler's diarrhea. Antimicrob Agents Chemother 38 (11):2668-70.
474. Wainwright, M. 1991. Streptomycin: Discovery and resultant controversy. Hist Philos Life Sci 13 (1):97-124.
475. Walsh, P. D., K. A. Abernethy, M. Bermejo, et al. 2003. Catastrophic ape decline in western equatorial Africa. Nature 422 (6932):611-14.
476. Walsh, P. D., R. Biek, and L. A. Real. 2005. Wave-like spread of Ebola Zaire. PLoS Biol 3 (11):e371.
477. Wammanda, R., and S. Onazi. 2009. Ability of mothers to assess the presence of fever in their children: Implication for the treatment of fever under the IMCI guidelines. Ann Afr Med 8 (3):173-76.
478. Watson-Jones, D., M. Oliff, F. Terris-Prestholt, et al. 2005. Antenatal syphilis screening in sub-Saharan Africa: Lessons learned from Tanzania. Trop Med Int Health 10 (9):934-43.
479. White, R. G., K. K. Orroth, J. R. Glynn, et al. 2008. Treating curable sexually transmitted infections to prevent HIV in Africa: Still an effective control strategy? J Acquir Immune Defic Syndr 47 (3):346-53.
480. WHO, World Health Organization. 1948. Constitution of the World Health Organization. Official Record of the World Health Organization. Geneva.
481. WHO, World Health Organization. 1973. Chemotherapy of malaria and resistance to antimalarials: Report of a WHO Scientific Group. WHO Technical Report Series 529:1-21.
482. WHO, World Health Organization. 1988. Aquired immune deficiency syndrome (AIDS), 1987 case definition for the CDC/WHO case definition for AIDS. Weekly Epidemiological Record 63:1-8.
483. WHO, World Health Organization. 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva: World Health Organization.
484. WHO, World Health Organization. 2001a. Interventions and strategies to improve the use of antimicrobials in developing countries. Geneva: World Health Organization.
485. WHO, World Health Organization. 2001b. WHO global strategy for containment of antibiotic resistance. Geneva: World Health Organization.
486. WHO, World Health Organization. 2003. Treatment of tuberculosis: Guidelines for national programmes. Geneva: World Health Organization.
487. WHO, World Health Organization. 2004. Global tuberculosis control-surveillance, planning, financing. Geneva: World Health Organization.
488. WHO, World Health Organization. 2005. Revision of the International Health Regulations. Geneva: World Health Organization.
489. WHO, World Health Organization. 2006a. Diagnostics for tuberculosis: Global demand and market potential. Geneva: World Health Organization.
490. WHO, World Health Organization. 2006b. Extensively drug-resistant tuberculosis (XDR-TB): Recommendations for prevention and control. Weekly Epidemiological Record 81:430-32.
491. WHO, World Health Organization. 2006c. Guidelines for the treatment of malaria.
492. WHO, World Health Organization. 2006d. The role of laboratory diagnosis to support malaria disease management: Focus on the use of rapid diagnostic tests in areas of high transmission.
493. WHO, World Health Organization. 2008. World malaria report.
494. WHO, World Health Organization. 2009a. Malaria Rapid Diagnostic Test Performance-results of WHO product testing of malaria RDTs: Round 1 (2008).
495. WHO, World Health Organization. 2009b. World malaria report.
496. WHO and CDC. 1998. Infection control for viral haemorrhagic fevers in the African health care setting.
497. WHO and UNICEF. 2003. The Africa Malaria Report. Geneva: World Health Organization and UNICEF.
498. WHO Regional Office for Africa. 2008. The Maputo Declaration on Strengthening of Laboratory Systems. Maputo, Mozambique, 24 January. http://www.finddiagnostics.org/export/sites/default/programs/scaling_up/lab_preparedness/docs/Maputo-Declaration_2008.pdf.
499. Wilson, I. K., D. G. Achel, M. D. Wilson, et al. 2003. The detection of tuberculosis in paucibacillary sputum samples in Ghana using PCR. Ghana Med J 37 (3):117-21.
500. Wilson, P. E., W. Kazadi, D. D. Kamwendo, V. Mwapasa, A. Purfield, and S. R. Meshnick. 2005. Prevalence of pfcrt mutations in Congolese and Malawian Plasmodium falciparum isolates as determined by a new Taqman assay. Acta Trop 93 (1):97-106.
501. Wolman, Dianne Miller, Andrea L. Kalfoglou, Lauren LeRoy, and Institute of Medicine (U.S.). Committee on Medicare Payment Methodology for Clinical Laboratory Services. 2000. Medicare laboratory payment policy: Now and in the future. Washington, D.C.: National Academy Press.
502. Wongsrichanalai, C., M. J. Barcus, S. Muth, A. Sutamihardja, and W. H. Wernsdorfer. 2007. A review of malaria diagnostic tools: Microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77 (6 Suppl):119-27.
503. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2 (4):209-18.
504. Woolhouse, M. E. 2002. Population biology of emerging and re-emerging pathogens. Trends Microbiol 10 (10 Suppl):S3-7.
505. Woolhouse, M. E., and S. Gowtage-Sequeria. 2005. Host range and emerging and reemerging pathogens. Emerg Infect Dis 11 (12):1842-47.
506. Wootton, David. 2006. Bad medicine: Doctors doing harm since Hippocrates. Oxford: Oxford University Press.
507. Worboys, Micheal. 2000. Colonial medicine. In Medicine in the 20th century, edited by R. Cooter and J. Pickstone. Amsterdam: Harwood Academic Publishers.
508. Wright, P. 2004. Aniru Conteh. Lancet 363 (9423):1831.
509. Xu, Q., S. G. Jin, and L. X. Zhang. 2000. Cost effectiveness of DOTS and non-DOTS strategies for smear-positive pulmonary tuberculosis in Beijing. Biomed Environ Sci 13 (4):307-13.
510. Yimer, S., G. Bjune, and G. Alene. 2005. Diagnostic and treatment delay among pulmonary tuberculosis patients in Ethiopia: A cross-sectional study. BMC Infect Dis 5 (1):112.
511. Zahra, A. 1956. Yaws eradication campaign in Nsukka division, Eastern Nigeria: A preliminary review. Bull World Health Organ 15:911-35.
512. Zhong, Nan Shan, and Guang Qiao Zeng. 2003. Our strategies for fighting Severe Acute Respiratory Syndrome (SARS). Am. J. Respir. Crit. Care Med. 168 (1):7-9.
513. Zimic, M., J. Coronel, R. H. Gilman, C. G. Luna, W. H. Curioso, and D. A. Moore. 2009. Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg 103 (6):638-40.
514. Zumla, A., J. Huggett, K. Dheda, C. Green, N. Kapata, and P. Mwaba. 2010. Trials and tribulations of an African-led research and capacity development programme: The case for EDCTP investments. Trop Med Int Health 15 (4):489-94.
515. Zurovac, D., B. A. Larson, W. Akhwale, and R. W. Snow. 2006. The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya. Trop Med Int Health 11 (8):1185-94.
516. Zurovac, D., B. Midia, S. A. Ochola, M. English, and R. W. Snow. 2006. Microscopy and outpatient malaria case management among older children and adults in Kenya. Trop Med Int Health 11 (4):432-40.
517. Zurovac, D., J. Njogu, W. Akhwale, D. H. Hamer, B. A. Larson, and R. W. Snow. 2008. Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya. Trop Med Int Health 13 (6):784-87.